PCN32 Cost Savings With Bevacizumab Compared to Sunitinib in the Treatment of MRCC

Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1133
https://www.valueinhealthjournal.com/article/S1098-3015(11)02695-7/fulltext
Title : PCN32 Cost Savings With Bevacizumab Compared to Sunitinib in the Treatment of MRCC
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02695-7&doi=10.1016/j.jval.2011.08.1133
First page : A439
Section Title : Cancer
Open access? : No
Section Order : 1090
Categories :
Tags :
Regions :
ViH Article Tags :